|
Table 3 Outcome measures
among the two groups
|
Variable
|
Misoprostol group
n= 198
|
Oxytol in group n=
204
|
p
|
Postpartum Haemorrhage
(= 500)* |
14(7%)
|
12 (6%)
|
0.628
|
| Drop in Hematocrit Level (%)# |
4.6%+/- 4.2
|
4.5%+/-4.1
|
0.675
|
| Drop in Haemoglobin level
(%)# |
1.4+/-1.3
|
1.3+/-1.2
|
0.674
|
Data are presented
as mean + SD, unless otherwise indicated
*Not statistically significant deference among groups (p > 0.05)
X2 (chi- square test)
#Not statistically significant deference among groups (p > 0.05)
t-test (student test)
|
|
A 10% drop in hematicrit was observed
from admission to day one postpartum occurred in 4.6% of the study
subjects and in of 4.5% of the control subjects (p=0.674).
There were no significant differences in the number of women who required
additional oxytocin to control bleeding after delivery. The length
of the third stage of labour was similar in both groups 10 and 8 minutes
respectively.
Regarding the side effects, shivering was observed with equal frequencies
in both groups ~10%. Other side effects as nausea, vomiting and diarrhoea
were the same in both groups. Similar neonatal outcomes (birth weight
and Apgar score) were observed in both groups.
 
|